As part of the preclinical development plan of the nanoGLA, we require the performance of the toxicological program in second species, which includes a 2-week Dose Range Finding (DRF) study in minipig.
The 2-week Dose Range Finding (DRF) study including analytical support, in minipigs is an essential study of preclinical drug development to ensure safety, dose selection, and regulatory compliance before initiating clinical trials. This study corresponds to WP1, Task 1.4 General Toxicology Studies from the Nano4Rare project.
All quotations must be submitted by 01/05/2026 to: info@delbios.com
Subject: SRD09-RFQ-TOX-007-2026
